TY - JOUR
T1 - Current updates on therapeutic advances in the management of cardiovascular diseases
AU - Jabir, Nasimudeen R.
AU - Siddiqui, Ali Nasir
AU - Firoz, Chelapram Kandy
AU - Ashraf, Ghulam Md
AU - Zaidi, Syed Kashif
AU - Khan, Mohd Shahnawaz
AU - Shakil, Shazi
AU - Alama, Mohammed Nabil
AU - Kamal, Mohammad Amjad
AU - Tabrez, Shams
N1 - Publisher Copyright:
© 2016 Bentham Science Publishers.
PY - 2016/2/1
Y1 - 2016/2/1
N2 - Despite the significant advances in the medical research and treatment methods, the rate of mortality associated with cardiovascular disease (CVD) is continuously rising and it remains the leading cause of death worldwide. There are several treatment methods for CVD and associated complications that have been considered till now. The current treatment methods cannot produce rapid cure, but could prevent or reduce the progression of this devastating disease. In the current article, we have summarized the use of various pharmacological agents viz. HMG-CoA reductase inhibitors (statins), antihypertensive, thrombolytic and anticoagulation agents that are currently being used for the management of CVD which targets different biochemical or molecular events. Based on our article, more research in this field is advocated which will provide the rapid and effective treatment methods in order to avoid fatal complications associated with CVD.
AB - Despite the significant advances in the medical research and treatment methods, the rate of mortality associated with cardiovascular disease (CVD) is continuously rising and it remains the leading cause of death worldwide. There are several treatment methods for CVD and associated complications that have been considered till now. The current treatment methods cannot produce rapid cure, but could prevent or reduce the progression of this devastating disease. In the current article, we have summarized the use of various pharmacological agents viz. HMG-CoA reductase inhibitors (statins), antihypertensive, thrombolytic and anticoagulation agents that are currently being used for the management of CVD which targets different biochemical or molecular events. Based on our article, more research in this field is advocated which will provide the rapid and effective treatment methods in order to avoid fatal complications associated with CVD.
KW - Anticoagulation agents
KW - Antihypertensive agents
KW - Antithrombolytic agents
KW - Statins
UR - http://www.scopus.com/inward/record.url?scp=84958280436&partnerID=8YFLogxK
U2 - 10.2174/1381612822666151125000746
DO - 10.2174/1381612822666151125000746
M3 - Article
C2 - 26601967
AN - SCOPUS:84958280436
SN - 1381-6128
VL - 22
SP - 566
EP - 571
JO - Current Pharmaceutical Design
JF - Current Pharmaceutical Design
IS - 5
ER -